dailystar.co.uk
60%
137
Covid-19 vaccine 'won't be ready for second wave' says Oxford professor as trial restarts
Covid-19 vaccine at Oxford University started suffering from a neurological disease that prompted developers AstraZeneca to order a “global shutdown” of all tests. The company’s chief executive, Pascal Soriot, reportedly told investors that the woman who had volunteered to take part in the trials was showing signs of an as yet undiagnosed neurological problem.In the same call, reports medical news site Statnews, Soriot revealed that the trial also had to be suspended July after one test subject started experiencing neurological problems.
